|
| Press Releases |
|
 |
|
| Tuesday, September 13, 2022 |
|
|
Indonesia's Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in manufacturing IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Friday, September 9, 2022 |
|
|
Indonesian pharmaceutical Bio Farma ready to produce IndoVac Covid-19 vaccines |
| PT Bio Farma, the holding company for state-owned pharmaceutical companies in Indonesia, announced a new milestone in the manufacturing process of IndoVac, a Covid-19 vaccine brand it has developed since November 2021. more info >> |
|
| Tuesday, July 19, 2022 |
|
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years |
| Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a two-dose series of 25 ug per dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6 months to 5 years. more info >> |
|
| Thursday, February 17, 2022 |
|
|
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years) |
| Moderna, Inc., (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Therapeutic Goods Administration (TGA) in Australia has granted provisional registration for the use of Moderna's mRNA COVID-19 vaccine, Spikevax, in a 50 ug dose, two-dose series, for active immunization to prevent COVID-19 caused by SARS-CoV-2 in children aged 6-11 years. more info >> |
|
| Wednesday, February 16, 2022 |
|
|
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries |
| Moderna, Inc., (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced plans to expand its commercial network across Asia with the addition of four new subsidiaries in Malaysia, Taiwan, Singapore, and Hong Kong. This expansion comes as the Company continues to scale up the manufacturing and distribution of its COVID-19 vaccine and future mRNA vaccines and therapeutics. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
中旅國際2022年全年綜合收入30.32億港元
Apr 1, 2023 11:58 HKT/SGT
|
|
|
中旅国际2022年全年综合收入30.32亿港元
Apr 1, 2023 11:57 HKT/SGT
|
|
|
China Travel International's Consolidated Revenue of HK$3,032 Million in 2022
Apr 1, 2023 11:56 HKT/SGT
|
|
|
綠地香港2022年收入266.14億，歸母淨利潤4.81億
Apr 1, 2023 11:03 HKT/SGT
|
|
|
绿地香港2022年收入266.14亿，归母净利润4.81亿
Apr 1, 2023 11:02 HKT/SGT
|
|
|
Indonesian MCI Ensures Telecommunication Access for Successful ASEAN Chairmanship 2023
Apr 1, 2023 01:00: JST
|
|
|
Indonesian MCI Ensures Telecommunication Access for Successful ASEAN Chairmanship 2023
Apr 1, 2023 00:00 HKT/SGT
|
|
|
ScamAdviser Coin 'Scams' the Internet for April Fools
Mar 31, 2023 22:45 HKT/SGT
|
|
|
ScamAdviser Coin 'Scams' the Internet for April Fools
Mar 31, 2023 22:45 HKT/SGT
|
|
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 21:15: JST
|
|
|
中国生物制药（1177.HK）公布2022全年业绩
Mar 31, 2023 21:13 HKT/SGT
|
|
|
中國生物製藥（1177.HK）公佈2022全年業績
Mar 31, 2023 21:12 HKT/SGT
|
|
|
Sino Biopharm (1177.HK) Announces 2022 Annual Results
Mar 31, 2023 21:11 HKT/SGT
|
|
|
ACROMETA Signs Sales & Purchase Agreement for Additional 40% of Life Science Incubator
Mar 31, 2023 20:15 HKT/SGT
|
|
|
联控2022年收入4,837亿 稳健经营 蓄力科创
Mar 31, 2023 19:22 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
